The beneficial effects of calcium channel blockers on long-term kidney transplant survival are independent of blood-pressure reduction

Clinical Transplantation

Volumn 14, Issue 3, 2000, Pages 257-261

  Mehrens, Thomas ^a   Thiele, Stefanie ^a   Suwelack, Barbara ^a   Kempkes, Manuela ^a   Hohage, Helge ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Calcium channel blocker; Hypertension; Kidney transplantation; Proteinuria; Transplant survival

Indexed keywords

ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; CYCLOSPORIN A; DILTIAZEM; NIFEDIPINE;

ADULT; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CLINICAL TRIAL; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; FOLLOW UP; GRAFT SURVIVAL; HUMAN; HYPERTENSION; KIDNEY GRAFT; NEPHROTOXICITY; PRIORITY JOURNAL; PROTEINURIA; SYSTOLIC BLOOD PRESSURE;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CREATININE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HUMANS; HYPERTENSION; KIDNEY TRANSPLANTATION; NIFEDIPINE; PROTEINURIA; RETROSPECTIVE STUDIES;

EID: 0034012596     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0012.2000.140313.x     Document Type: Article

References (20)

1. HOHAGE H, BRÜCKNER D, ARLT M, BUCHHOLZ B, ZIDEK W, SPIEKER C. Influence of cyclosporine A and FK 506 on 24 h blood pressure monitoring in kidney transplant recipients. Clin Nephrol 1996: 45: 342.
2. MOURAD G, RIBSTEIN J, MIMRAN A. Converting-enzyme inhibitor versus calcium antagonist in cyclosporine-treated renal transplants. Kidney Int 1993: 43: 419.
3. KOKADO Y, TAKAHARA H, KAMEOKA H, OKUYAMA A. Hypertension in renal transplant recipients and its effects on long-term renal allograft survival. Transplant Proc 1996: 28: 1600.
4. VERSLUIS DJ, WENTING GJ, DERKX FHM, SCHALEKAMP MADH, JEEKEL J, WEIMAR W. Who should be converted from cyclosporine to convential immunosuppression in kidney transplantation, and why? Transplantation 1987: 44: 387.
5. NEUMAYER HH, KUZENDORF U, SCHREIBER M. Protective effects of calcium antagonists in human renal transplantation. Kidney Int 1992: 41 (suppl. 36): S87.
6. SUTHANTHIRAN M, HASCHEMAYER RH, RIGIO RR, ADUBOR D, FRIEDMAN G, CHEIGH JS, WANG JC, FONTINO M, STUBENBORD WT, SAAL SD, STENZEL KH, RUBIN AL. Excellent outcome with a calcium channel blocker supplemented immunosuppressive regimen in cadaveric renal transplantation. Transplantation 1993: 55: 1008.
7. WAGNER K, ALBRECHT S, NEUMAYER H. Prevention of post-transplant acute tubular necrosis by the calcium antagonist diltiazem: a prospective randomized study. Am J Nephrol 1987: 7: 287.
8. LUSTIG S, SHMUELI D, BONER G, BAR-NATHAN N, NAKACHE R, YUSSIM A, SHAHRABANI E, SHAPIRA Z. Gallopamil reduces the post-transplantation acute tubular necrosis in kidney from aged donors. Isr J Med Sci 1996: 32: 1249.
9. SHIN GT, CHEIGH JS, RIGGIO RR, STUBENBORD WT, SERUR D, WANG JC, RUBIN AL, STENZEL KH. Effect of nifedipine on renal allograft function and survival beyond one year. Clin Nephrol 1997: 47: 33.
10. EUROPEAN MULTICENTER TRIAL GROUP. Cyclosporine in cadaveric renal transplantation: 10-year follow-up of a multicenter trial. T. Beveridge, Calne RY. Transplantation 1995: 59: 1568.
11. HOHAGE H, KLEYER U, BRÜCKNER D, AUGUST C, ZIDEK W, SPIEKER C. Influence of Proteinuria on long-term transplant survival in kidney transplant recipients. Nephron 1997: 75: 160.
12. MORALES JM, ANDRES A, RODRIGUEZ PE, PATERNINA ER, MONTOYO AC, RODICIO JL. Calcium antagonist therapy prevents chronic cyclosporine nephrotoxicity after renal transplantation. Transplant Proc 1992: 24: 89.
13. NICHOLSON ML, DENNIS MJS, BECKINGHAM IJ, SMITH SJ. Effect of nifedipine on renal transplant rejection. Br J Surg 1993: 80: 1318.
14. LOUTZENHISER R, EPSTEIN M. Renal microvascular actions of calcium antagonists. J Am Soc Nephrol 1990: 1: S3.
15. DELMONICO FL, CONTI D, AUCHINCLOSS JH, RUSSEL PS, TOLKOFF-RUBIN N, FANG LT, COSIMI B. Long-term, low dose cyclosporine treatment of renal allograft recipients. Transplantation 1990: 49: 899.
16. BURKE JF, PIRSCH JD, RAMOS EL, SALOMON DR, STABLEIN D, VAN BUREN DH, WEST JC. Long term efficiency and safety of cyclosporine in renal transplant recipients. N Engl J Med 1994: 331: 358.
17. WEIR MR, SUTHANTHIRAN M. Supplementation of immunosuppressive regimen with a calcium channel blockers. Clin Immunother 1994: 2: 458.
18. RUGGENENTI P, PERICO N, MOSCONI L, GASPARI F, BENIGNI A, AMUCHASTEGUI CS, BRUZZI I, REMUZZI G. Calcium channel blockers protect transplant patients from cyclosporine-induced daily renal hypoperfusion. Kidney Int 1993: 43: 706.
19. VASQUEZ EM, POLLACK R. Effect of calcium channel blockers on graft outcome in cyclosporin-treated allograft recipients. Transplantation 1995: 60: 885.
20. BARENBROCK M, COLMORGEN U, FIRSCHKA E, GELLERT J, LIPPERT J, SCHRÖDER K, SPIEKER C, VOIGT-LADNER G, WAGNER K, NEUMAYER HH, RAHN KH. A multicenter, randomized, double blind, placebo-controlled, two-year trial to study the effect of nitrendipine on chronic renal transplant function. Clin Nephrol 1997: 41: 388.